<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dietary <z:chebi fb="7" ids="26208">polyunsaturated fatty acids</z:chebi> (PUFAs) can be converted to <z:chebi fb="11" ids="26333">prostaglandins</z:chebi> and <z:chebi fb="0" ids="25029">leukotrienes</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Oxygenation of omega-6 PUFAs generally results in the production of pro-<z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, whereas oxygenated products of omega-3 (n-3) PUFAs generally have lower inflammatory activity </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesize that elevated n-3 PUFA intakes from fish are associated with lower risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> among those with genetic variants that result in higher levels of pro-<z:mp ids='MP_0002501'>inflammatory mediators</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In population-based case-control studies of colon (case n = 1,574) and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (case n = 791) and disease-free controls (n = 2,969), we investigated interactions between dietary fatty acid intake and 107 candidate polymorphisms and tagSNPs in PTGS1, PTGS2, ALOX12, ALOX5, ALOX15, and FLAP </plain></SENT>
<SENT sid="4" pm="."><plain>The two studies used an identical genotyping protocol </plain></SENT>
<SENT sid="5" pm="."><plain>We observed interactions and statistically significant increases in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> risk for low <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi> intake among those with the PTGS1 rs10306110 (-1,053 A &gt; G) variant genotypes (OR = 1.6, 95 % confidence interval = 1.1-2.3, adj. p = 0.06) and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> risk for low total fat intake among those with the variant PTGS1 rs10306122 (7,135 A &gt; G) (OR(vs.wt) = 1.80, 1.02-2.99; adj. p = 0.08) </plain></SENT>
<SENT sid="6" pm="."><plain>The ALOX15 rs11568131 (10,339 C &gt; T) <z:mp ids='MP_0002169'>wild type</z:mp> in combination with a high <z:mp ids='MP_0001845'>inflammation</z:mp> score (low <z:chebi fb="113" ids="28364">EPA</z:chebi> intake, high AA intake, no regular <z:chebi fb="1" ids="35475">NSAID</z:chebi> use, high BMI, smoking) was associated with increased <z:hpo ids='HP_0003003'>colon cancer</z:hpo> risk (OR = 2.28, 1.7-3.07) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">Rectal cancer</z:e> risk was inversely associated with a low <z:mp ids='MP_0001845'>inflammation</z:mp> score among PTGS2 rs4648276 (3,934 T &gt; C) variant allele carriers (OR = 0.49, 0.25-0.75) </plain></SENT>
<SENT sid="8" pm="."><plain>Overall, these data provide some modest evidence for interactions between dietary fat intake and genetic variation in genes involved in eicosanoid metabolism and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
</text></document>